Differential inhibition of human cancer cell proliferation by citrus limonoids.

Limonoids have been shown to inhibit the growth of estrogen receptor-negative and -positive human breast cancer cells in culture. The primary objective of this study was to test the antiproliferative activity of limonoids (obacunone 17[beta]-D-glucopyranoside, nomilinic acid 17[beta]-D-glucopyranosi...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition & Cancer Vol. 40; no. 2; pp. 180 - 185
Autores principales: Tian Q, Miller EG, Ahmad H, Tang L, Patil BS
Formato: Journal Article
Publicado: Taylor & Francis Ltd 2001
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106096370&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106096370
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01635581
        7MS
      jtl: Nutrition & Cancer
      issn: 01635581
      maglogo: N
    pubinfo:
      dt: 2001
      vid: 40
      iid: 2
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        106096370
        2009444858
        NLM11962254
        106096370
      ppf: 180
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Differential inhibition of human cancer cell proliferation by citrus limonoids.
      aug:
        au:
          Tian Q
          Miller EG
          Ahmad H
          Tang L
          Patil BS
      sug:
        subj:
          Cell Physiology Drug Effects
          Citrus
          Hydrocarbons Pharmacodynamics
          Hydrocarbons
          Neoplasms Pathology
          Apoptosis Drug Effects
          Benzopyrans Pharmacodynamics
          Breast Neoplasms Pathology
          Cells
          Cervix Neoplasms Pathology
          DNA Analysis
          Female
          Flow Cytometry
          Glycosides Pharmacodynamics
          Heterocyclic Compounds Pharmacodynamics
          Leukemia Pathology
          Liver Neoplasms Pathology
          Ovarian Neoplasms Pathology
          Plant Extracts
          Stomach Neoplasms Pathology
          Female
      ab: Limonoids have been shown to inhibit the growth of estrogen receptor-negative and -positive human breast cancer cells in culture. The primary objective of this study was to test the antiproliferative activity of limonoids (obacunone 17[beta]-D-glucopyranoside, nomilinic acid 17[beta]-D-glucopyranoside, limonin, nomilin, and a limonoid glucoside mixture), found in high concentrations in mandarin (Citrus reticulata Blanco), against a series of human cancer cell lines. The human cancer cell lines included leukemia (HL-60), ovary (SKOV-3), cervix (HeLa), stomach (NCI-SNU-1), liver (Hep G2), and breast (MCF-7). The growth-inhibitory effects of the four limonoids and the limonoid glucoside mixture against MCF-7 cells were significant, and the antiproliferative activity of the different citrus limonoids was also dose and time dependent. No significant effects were observed on growth of the other cancer cell lines treated with the four individual limonoids at 100 [mu]g/ml. At 100 ?g/ml, the limonoid glucoside mixture demonstrated a partial inhibitory effect on SKOV-3 cancer cells. With use of flow cytometry, it was found that all the limonoid samples could induce apoptosis in MCF-7 cells at relatively high concentrations (100 [mu]g/ml). Considering the high concentration needed to induce apoptosis, it is unlikely that this is the primary mechanism of action for the cytotoxic effects seen with limonoids in this study. Further work is needed in this area to establish the mechanism of action of citrus limonoids on human breast cancer cells.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N